Picture of Valbiotis SA logo

ALVAL — Valbiotis SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Valbiotis: Research Partnership In Intestinal Microbiota With MEDIS Unit From Clermont Auvergne University

Dec 14 (Reuters) - Valbiotis SA  ALVAL.PA :
    * VALBIOTIS ANNOUNCES SIGNATURE OF A RESEARCH PARTNERSHIP IN
INTESTINAL MICROBIOTA WITH MEDIS UNIT FROM CLERMONT AUVERGNE
UNIVERSITY
    * THIS WORK WILL MAKE IT POSSIBLE TO DEVELOP THE WORLD'S
MOST
COMPLETE MODEL OF THE HUMAN UPPER DIGESTIVE TRACT BY 2024,
INTEGRATING IN PARTICULAR THE MICROBIOTA OF THE SMALL INTESTINE.
    * EXPECTED RESULTS WILL SUPPORT NON-DRUG STRATEGIES AGAINST
METABOLIC AND CARDIOVASCULAR DISEASES DEVELOPED BY VALBIOTIS
    * MIMETIV PROJECT WILL PROVIDE PROPRIETARY DATA ON
METABOLITES,
BIOAVAILABILITY, MODE OF ACTION AT INTESTINAL LEVEL AND EFFECTS
ON THE HUMAN MICROBIOTA OF THESE TWO ACTIVE SUBSTANCES

Source text for Eikon:  ID:nBwbjXt9qa 
Further company coverage:  ALVAL.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Valbiotis SA

See all news